Seizure Recurrence and Developmental Disabilities After Neonatal Seizures: Outcomes Are Unrelated to Use of Phenobarbital Prophylaxis

Abstract

This study investigated treatment patterns at discharge in infants with neonatal seizures and evaluated the impact of outpatient phenobarbital prophylaxis on the frequency of seizure recurrence and the long-term neurodevelopmental outcome at 1 to 11 years. Infants with neonatal seizures during a 12-year period were identified retrospectively (n = 146), and data were obtained by medical chart review. Outcomes were ascertained by standardized telephone survey. Thirty-three infants (23%) were taking phenobarbital, and 99 infants (68%) were taking no anticonvulsants at discharge. Comparisons were made between these 2 groups. Phenobarbital prophylaxis did not improve neurologic outcomes, either with respect to seizure recurrence or neurologic development. These data have important implications at a time when many are questioning the practice of prophylaxis after neonatal seizures and when newer anticonvulsants are being recommended for treatment of acute neonatal seizures.

Keywords

neonatal seizures phenobarbital developmental disabilities

Get full access to this article

View all access options for this article.

References

Evans D. , Levene M. Neonatal seizures. Arch Dis Child Fetal Neonatal Ed. 1998;78:F70-F75.

Boer HR , Gal P. Neonatal seizures: a survey of current practice. Clin Pediatr (Phila). 1982;21:453-457.

Massingale TW , Buttross S. Survey of treatment practices for neonatal seizures. J Perinatol. 1993;13:107-110.

Brod SA , Ment LR , Ehrenkranz RA , Bridgers S. Predictors of success for drug discontinuation following neonatal seizures . Pediatr Neurol. 1988;4:13-17.

Clancy RR , Legido A. Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia. 1991;32:69-76.

Legido A. , Clancy RR , Berman PH Neurologic outcome after electroencephalographically proven neonatal seizures . Pediatrics. 1991;88:583-596.

Diaz J. Disruption of the brain growth spurt in adolescent rats by chronic phenobarbital administration. Exp Neurol. 1983; 79:559-563.

Diaz J. , Schain RJ Phenobarbital: effects of long-term administration on behavior and brain of artificially reared rats. Science. 1978;199:90-91.

Diaz J. , Schain RJ , Bailey BG Phenobarbital-induced brain growth retardation in artificially reared rat pups. Biol Neonate. 1977;32:77-82.

10.

Gal P. Anticonvulsant therapy after neonatal seizures—how long should it be continued? I. A case for early discontinuation of anticonvulsants. Pharmacotherapy. 1985;5:268-273.

11.

Holmes GL , Ben-Ari Y. Seizures in the developing brain: perhaps not so benign after all . Neuron. 1998;21:1231-1234.

12.

Sogawa Y. , Monokoshi M. , Silveira DC , et al. Timing of cognitive deficits following neonatal seizures: relationship to histological changes in the hippocampus. Brain Res Dev Brain Res. 2001; 131:73-83.

13.

Mizrahi EM Neonatal seizures: problems in diagnosis and classification. Epilepsia. 1987;28(suppl 1):S46-S55.

14.

Msall ME , DiGaudio K. , Duffy LC , et al. WeeFIM. Normative sample of an instrument for tracking functional independence in children. Clin Pediatr (Phila). 1994;33:431-438.

15.

Msall ME , DiGaudio K. , Rogers BT , et al. The Functional Independence Measure for Children (WeeFIM). Conceptual basis and pilot use in children with developmental disabilities. Clin Pediatr (Phila). 1994;33:421-430.

16.

Hosmer DW , Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, NY: John Wiley & Sons Inc; 1999.

17.

Scher MS Seizures in the newborn infant. Diagnosis, treatment, and outcome. Clin Perinatol. 1997;24:735-772.

18.

Andre M. , Matisse N. , Vert P. , Debruille C. Neonatal seizures— recent aspects. Neuropediatrics. 1988;19:201-207.

19.

Hellstrom-Westas L. , Blennow G. , Lindroth M. , et al. Low risk of seizure recurrence after early withdrawal of antiepileptic treatment in the neonatal period. Arch Dis Child Fetal Neonatal Ed. 1995;72:F97-F101.

20.

Scher MS , Aso K. , Beggarly ME , et al. Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae. Pediatrics. 1993;91:128-134.

21.

Painter MJ , Gaus LM Neonatal seizures: diagnosis and treatment. J Child Neurol. 1991;6:101-108.

22.

Holden KR , Mellits ED , Freeman JM Neonatal seizures. I. Correlation of prenatal and perinatal events with outcomes . Pediatrics. 1982;70:165-176.

23.

Toet MC , Groenendaal F. , Osredkar D. , et al. Postneonatal epilepsy following amplitude-integrated EEG-detected neonatal seizures. Pediatr Neurol. 2005;32:241-247.

24.

Hernandez TD , Holling LC Disruption of behavioral recovery by the anti-convulsant phenobarbital. Brain Res. 1994;635:300-306.

25.

Farwell JR , Lee YJ , Hirtz DG , et al. Phenobarbital for febrile seizures—effects on intelligence and on seizure recurrence. N Engl J Med. 1990 ;322:364-369.

26.

Sulzbacher S. , Farwell JR , Temkin N. , et al. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr (Phila). 1999;38:387-394.

27.

van der Pol MC , Hadders-Algra M. , Huisjes HJ , Touwen BC Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. Am J Obstet Gynecol. 1991;164:121-128.

28.

Tennison M. , Greenwood R. , Lewis D. , Thorn M. Discontinuing antiepileptic drugs in children with epilepsy. A comparison of a six-week and a nine-month taper period. N Engl J Med. 1994; 330:1407-1410.